Loading clinical trials...
Loading clinical trials...
A Phase III, 6-Month Self-selection and Actual Use Study for Rx-to-OTC Switch of Rosuvastatin 5 mg Once-daily in Combination With a Web App
Conditions
Interventions
5 mg rosuvastatin calcium with a Web App (combination product)
Locations
1
United States
Research Site
Indianapolis, Indiana, United States
Start Date
July 8, 2021
Primary Completion Date
March 1, 2023
Completion Date
March 1, 2023
Last Updated
October 30, 2024
NCT07220213
NCT07126587
NCT06364163
NCT05720156
NCT06350604
NCT06227819
Lead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions